Public Health Impact of Using Biosimilars, Is Automated Follow up Relevant?
Biologic reference drugs and their copies, biosimilars, have a complex structure. Biosimilars need to demonstrate their biosimilarity during development but unpredictable variations can remain, such as micro-heterogeneity.
- Ref: Int J Environ Res Public Health. 2020 Dec 29;18(1):186.
- Année de publication : 2020
- Auteurs : Perpoil A, Grimandi G, Birklé S, Simonet JF, Chiffoleau A, Bocquet F.
- Réseaux : Réseaux: non classé